KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to -$50.9 million.

  • Resmed's Cash from Investing Activities fell 3883.68% to -$50.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$269.0 million, marking a year-over-year decrease of 13555.39%. This contributed to the annual value of -$200.0 million for FY2025, which is 2584.99% up from last year.
  • Latest data reveals that Resmed reported Cash from Investing Activities of -$50.9 million as of Q4 2025, which was down 3883.68% from -$52.6 million recorded in Q3 2025.
  • Resmed's Cash from Investing Activities' 5-year high stood at $2.1 million during Q3 2024, with a 5-year trough of -$1.0 billion in Q4 2022.
  • Over the past 5 years, Resmed's median Cash from Investing Activities value was -$48.8 million (recorded in 2021), while the average stood at -$103.5 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first surged by 10144.05% in 2024, then plummeted by 255004.66% in 2025.
  • Over the past 5 years, Resmed's Cash from Investing Activities (Quarter) stood at -$83.3 million in 2021, then crashed by 1132.07% to -$1.0 billion in 2022, then soared by 95.99% to -$41.1 million in 2023, then rose by 10.82% to -$36.7 million in 2024, then tumbled by 38.84% to -$50.9 million in 2025.
  • Its last three reported values are -$50.9 million in Q4 2025, -$52.6 million for Q3 2025, and -$133.7 million during Q2 2025.